UK's Hikma drops after tightening annual profit forecast

Hikma Pharmaceuticals

Today 08:10

** Shares of British drugmaker Hikma Pharmaceuticals HIK.L fall 2% to 1,726p
** Co now expects full-year operating profit of $740 mln to $760 mln, compared with previous forecast of $720 mln to $770 mln
** Hikma reiterates overall annual revenue growth target of 2% to 4%, says demand across the Middle East and North Africa has remained robust
** As of last close, HIK up ~14% YTD

 (Reporting by Amna Mariyam in Bengaluru)
 ((amna.mariyam@thomsonreuters.com; +91 8448625620))